Spironolactone Tablet, Film Coated
Product Images NDC 68382-662

6 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68382-662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone showing its steroidal core with ketone and thioacetate functional groups.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival plot comparing the probability of an event over 42 months between two groups: Spironolactone (n=822) and Placebo (n=841). The plot shows time in months on the x-axis and probability on the y-axis, illustrating a statistically significant difference (Log-rank p < 0.001) with Spironolactone having a higher probability curve than Placebo.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CI) for the effect of spironolactone across various subgroups including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot compares spironolactone with placebo, indicating subgroup sample sizes and percentage distributions.*
FDA Label Image

Image4 (19dcadf3 8242 413a 9a0d A2181ef1e2ff 04)

Image4 (19dcadf3 8242 413a 9a0d A2181ef1e2ff 04)
Label for Spironolactone Tablets USP, 25 mg film-coated tablets, containing 100 tablets per bottle. The label indicates prescription use (Rx only) with storage instructions, manufacturer Zydus Lifesciences Ltd., and distributor Zydus Pharmaceuticals (USA) Inc. It includes dosage and safety information, barcode, and NDC 68382-660-01.*
FDA Label Image

Image5 (19dcadf3 8242 413a 9a0d A2181ef1e2ff 05)

Image5 (19dcadf3 8242 413a 9a0d A2181ef1e2ff 05)
Spironolactone Tablets, USP 50 mg film-coated tablet label from Zydus Pharmaceuticals (USA) Inc. The label indicates a package size of 100 tablets with dosage strength prominently displayed in a purple box. It includes storage instructions, child resistance notice, manufacturer and distributor information, and a barcode on the left. The label is primarily white with purple and black text.*
FDA Label Image

Image6 (19dcadf3 8242 413a 9a0d A2181ef1e2ff 06)

Image6 (19dcadf3 8242 413a 9a0d A2181ef1e2ff 06)
Label for Spironolactone Tablets, USP 100 mg film-coated tablets by Zydus Pharmaceuticals (USA) Inc. The label indicates a package size of 100 tablets, Rx only, with storage and handling instructions including child-resistant packaging and protection from light. Manufacturer details for Zydus Lifesciences Ltd., India, and distributor information in Pennington, NJ, are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.